跳至主要内容
临床试验/NL-OMON25952
NL-OMON25952尚未招募不适用

Phase III effectiveness multicenter randomized clinical trial in Patients with Juvenile Idiopathic Arthritis and Methotrexate related side effects: Psychological Behavioural therapy versus switch to MTX parenteral versus standard of care.

none (investigator driven)0 个研究点目标入组 130 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
130

研究概览

简要总结

pilot study submitted to Clin Exp Rheumatology

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Diagnosis: all subtypes JIA according to ILAR classification;
  • 2. Ages 4 to 17 years;
  • 3. MTX oral (dosing 10-20mg/m2/week);
  • 4. Other medication: NSAID, biologicals (etanercept, infliximab, anakinra) allowed.

排除标准

  • 1. MTX parenteral;
  • 2. Other diagnosis;
  • 3. Steroid usage (more than 0.2mg/kg/day);
  • 4. Other MTX related side effects.

研究者

发起方
none (investigator driven)

相似试验